ArticleEClinicalMedicine2026

RAS/MAPK pathway modulation with simvastatin in children with Noonan syndrome: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial.

Thomas Edouard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.